Advertisement

Organisation › Details
Curetis GmbH
Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques. To date, Curetis has raised EUR 44.3 million in an IPO on Euronext Amsterdam and Euronext Brussels and private equity funds of over EUR 63.5 million. The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia. *
![]() |
Start | 2016-03-15 established (reorg) |
Group | OpGen (Group) | |
Predecessor | Curetis AG | |
![]() |
Industry | Unyvero molecular diagnostics platform |
Industry 2 | Unyvero P50™ pneumonia cartridge | |
![]() |
Person | Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO) |
Person 2 | Boos, Andreas (Curetis 200812– Managing Director) | |
![]() |
Region | Holzgerlingen |
Country | Germany | |
Street | 42 Max-Eyth-Str. | |
City | 71088 Holzgerlingen | |
Tel | +49-7031-49195-10 | |
Address record changed: 2022-09-17 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-12-29 |
Advertisement

More documents for OpGen (Group)
- [1] OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD....
- [2] OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection"....
- [3] OpGen, Inc.. (12/9/20). "Press Release: OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics". Gaithersburg, MD & Vienna....
- [4] OpGen, Inc.. (11/24/20). "Press Release: OpGen, Inc. Announces $10 Million Private Placement Priced at the Market". Gaithersburg, MD....
- [5] OpGen, Inc.. (10/28/20). "Press Release: OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators". Gaithersburg, MD & Holzgerlingen....
- [6] Sphingotec GmbH. (4/16/20). "Press Release: SphingoTec Expands Leadership Team and Appoints Achim Plum as Managing Director and Chief Commercial Officer". Hennigsdorf....
- [7] Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA....
- [8] OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD....
- [9] Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen....
- [10] OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top